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Protein kinases catalyze protein phosphorylation
and thereby control the flow of information through
signaling cascades. Currently available methods for
concomitant assessment of the enzymatic activities
of multiple kinases in complex biological samples
rely on indirect proxies for enzymatic activity, such
as posttranslational modifications to protein kinases.
Our laboratories have recently described a method
for directly quantifying the enzymatic activity of
kinases in unfractionated cell lysates using sub-
strates containing a phosphorylation-sensitive un-
natural amino acid termed CSox, which can bemoni-
tored using fluorescence. Here, we demonstrate the
utility of this method using a probe set encompass-
ing p38a, MK2, ERK1/2, Akt, and PKA. This panel of
chemosensors provides activity measurements of
individual kinases in a model of skeletal muscle dif-
ferentiation and can be readily used to generate indi-
vidualized kinase activity profiles for tissue samples
from clinical cancer patients.
INTRODUCTION
Current techniques for analyzing the signaling dynamics of
multiple protein kinases in complex samples use proxies for
kinase activity, such as antibody- or mass spectrometry-based
analysis of phosphorylation states (Choudhary and Mann,
2010; Nielsen et al., 2003; O’Neill et al., 2006; Xiao et al., 2010).
In one embodiment of this approach, the activities of target
kinases are inferred through analysis of the phosphorylation
state of specific substrates. For example, activation of PKA is
often demonstrated through the phosphorylation of its down-
stream substrate CREB (Chen et al., 2005; Gonzalez and Mont-
miny, 1989). These inferences of enzymatic activity generally
lack a temporal component, making the interpretation of enzy-
matic rates difficult. In a complementary approach, the activation
of particular kinases is inferred through the phosphorylation state
of those kinases. Coupling this antibody-based approach with210 Chemistry & Biology 19, 210–217, February 24, 2012 ª2012 Elseisoelectric focusing allows for quantitative measurement of the
phosphorylation status of a kinase (O’Neill et al., 2006). However,
measurements of activating phosphorylationmodifications on an
individual kinase are inherently univariate and do not take into
account other cellular processes, such as additional posttrans-
lational modifications that may affect kinase activity (Chen
et al., 2001). Indeed, activating phosphorylation modifications
of a particular kinase do not always correlate with its enzymatic
activity (Kumar et al., 2007). This has prompted a shift away
fromanalysis of proxies for kinase activation toward the develop-
ment of sensors capable of reporting directly on the enzymatic
activity of a particular kinase. Notably, FRET-based sensors,
incorporating genetically encodable fluorescent proteins, have
been used to detect kinase activity in living cells (Kunkel et al.,
2007; Sato et al., 2007). However, these probes often only pro-
duce modest increases in fluorescence of 20%–60% upon
phosphorylation (Rothman et al., 2005), and their application in
tissues isolated from clinical patients has not been demon-
strated. Recently, the Lawrence laboratory observed that
tyrosine phosphorylation alleviates quenching of a proximal fluo-
rophore (Wang et al., 2006). This phenomenon was utilized to
generate orthogonal activity probes capable of monitoring two
tyrosine kinase activities simultaneously (Wang et al., 2010).
Although elegant, this strategy is currently restricted to tyrosine
kinases and does not allow for analysis of serine/threonine
kinase activities, which constitute important downstream sig-
naling nodes within cellular pathways.
In order to address these issues, our laboratories developed
a technique in which a phosphorylation-sensitive fluorescent
amino acid, Sox, is used to monitor kinase activity in unfractio-
nated cell lysates (Shults et al., 2005). Phosphorylation at a
proximal residue dramatically increases the affinity of Sox for
Mg2+, leading to an increase in fluorescence, a process termed
chelation-enhanced fluorescence (Shults and Imperiali, 2003).
This sensing modality is general and can be applied to sub-
strates for both tyrosine and serine/threonine kinases. Recently,
we have extended this strategy through the development of
a second-generation cysteine derivative of the Sox fluorophore,
which we term CSox (Lukovic et al., 2008) (Figures 1A and 1B).
The increased flexibility of CSox allows for incorporation
of both N- and C-terminal kinase recognition elements into
second-generation probes, leading to improved selectivity and
kinetic properties as well as lower sample demand. We havevier Ltd All rights reserved
Figure 1. CSox-Based Kinase Activity Probes
(A) Phosphorylation of a kinase substrate containing CSox leads to chelation of
Mg2+ and an increase in CSox fluorescence.
(B) Phosphorylation can be directly monitored in unfractionated lysates by
exciting at 360 nm and measuring emission at 485 nm. The rate of increase in
fluorescence is proportional to enzymatic activity.
(C) A panel of selective kinase activity sensors with corresponding kinetic
parameters is shown (Lukovic et al., 2008, 2009; Stains et al., 2011). The CSox
amino acid and sites of phosphorylation are underlined. The p38a sensor
contains a flexible 8-amino-3,6-dioxaoctanoic acid (AOO) linker between
a p38a peptide-based docking sequence and phosphorylation site (Stains
et al., 2011), whereas the CSox phosphorylation site of the ERK1/2 sensor
is ligated to a protein docking domain for ERK1/2 (Lukovic et al., 2009).
Canonical pathways for each kinase are indicated.
See also Figure S1.
Figure 2. Longitudinal Kinase Activity Dynamics During Differentia-
tion of C2C12 Cells
A hierarchal clustering analysis of fold changes in kinase activity relative to
cells grown under mitogen-rich conditions demonstrates clustering of kinases
based on similar trends in activity.
See also Figure S2 and Movie S1.
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MK2, Akt, and PKA (Lukovic et al., 2008; Lukovic et al., 2009;
Shults et al., 2005; Stains et al., 2011) and have derived kinetic
parameters for each substrate (Figure 1C). The selectivity of
the p38a and ERK1/2 sensors has been verified using a panel
of recombinant kinases with potential overlapping substrate
specificity as well as unfractionated cell lysates in combina-
tion with inhibitors and immunodepletions (Lukovic et al., 2009;
Stains et al., 2011). In a similar manner, the selectivity of
second-generation CSox sensors for MK2, Akt, and PKA
(Lukovic et al., 2008) were evaluated in unfractionated cell
lysates through the use of inhibitor assays and immunodeple-
tions, demonstrating that these sensors are also selective for
the targeted kinase (Figure S1 available online). Importantly,
the improved catalytic efficiency of the MK2 and Akt second-
generation sensors (Lukovic et al., 2008) (10- and 23-fold re-
spectively), compared with our previous design (Shults et al.,
2005), allows for decreased sample and substrate demand while
maintaining assay performance. In addition, off-target kinase
inhibitorsmay be removed from theMK2 assaywhilemaintaining
selectivity (Figure S1).
The above panel of selective kinase activity sensors has
the potential to provide information concerning signaling flux
through biologically important pathways that impinge upon cell
survival, growth, metabolism, and inflammatory responses (Fig-
ure 1C). To demonstrate the utility of this panel, we used it two
different ways—namely, longitudinally and latitudinally. In theChemistry & Biology 19, 210first, we delineate perturbations in multipathway signaling
network activities during skeletal muscle differentiation; in the
second, we compare multipathway signaling network activities
between diseased and normal tissue in individual human tumors,
potentially clarifying previously ambiguous roles for kinases
within the panel. These experiments highlight the utility of direct
activity measurements in providing unique information concern-
ing operative signaling pathways.
RESULTS AND DISCUSSION
A Longitudinal Analysis of Kinase Activity during
Skeletal Muscle Differentiation
We began with a study aimed to determine how multiple kinase
activities might vary during a time course of cellular differentia-
tion. We selected skeletal muscle differentiation as an important
example application and implemented the well-studied C2C12
mouse myoblast cell line. These mononucleated progenitor cells
can be induced to exit the cell cycle and differentiate into fused
multinucleated myotubes upon mitogen withdrawal (Figure S2)
and display characteristic phenotypic changes such as sponta-
neous contraction (Movie S1). C2C12 lysates were prepared
after mitogen withdrawal over a 5-day period, and, in addition
to the phenotypic changes noted above, differentiation was
confirmed by monitoring the expression of early and late stage
markers (Figure S2).
Having established the phenotypic differentiation process,
we determined the activity of each kinase in the panel relative
to myoblasts grown under mitogen-rich conditions for two
independent preparations of cell lysates (Figure S2). Relative
changes in kinase activity were used in hierarchical clustering
analysis to identify activities which correlate with differentiation
(Figure 2). This analysis identified three clusters that showed
distinct activity profiles. Cluster 1 contained PKA and Akt activ-
ities, which were positively correlated with differentiation (Fig-
ure 3A). In addition, western blot analysis of phospho-Akt levels
correlated well with the direct Akt activity assays and indicated
that the increase in observed Akt activity may be due to an
increase in Akt expression (Figure 3A, inset). These data support
previous observations indicating that both PKA and Akt are–217, February 24, 2012 ª2012 Elsevier Ltd All rights reserved 211
Figure 3. Relative Activity Trends of Kinases during Differentiation of C2C12 Cells
(A–C) Fold changes in activity for clusters 1, 2, and 3, respectively. Activity assays demonstrate linkages between pathways that are operative during
differentiation, and insets within each panel show western blots for the corresponding phosphokinase with tubulin as a loading control. Relative changes in
activity are the average of six total activity assays performed on two independently prepared C2C12 cell lysates ± SEM.
(D) Western blot analysis of p38a and g expression during C2C12 differentiation. Tubulin serves as a loading control.
See also Figure S2 and Movie S1.
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Interrogating Signaling via Kinase Activity Probespositive regulators of myogenesis (Chen et al., 2005; Fujio et al.,
1999; Mukai and Hashimoto, 2008; Rommel et al., 1999). Cluster
2 activity, which includes ERK1/2 andMK2, displayed a biphasic
activity profile (Figure 3B). Biphasic ERK1/2 activity has been
previously observed using western blot analysis and did not
correlatewithERKexpression (Figure 3B, inset). ThisERKactivity
profile is thought to facilitate exit from the cell cycle (Rommel
et al., 1999; Tagawa et al., 2008). Interestingly, MK2 activity
displays a similar activity profile, which is in agreement with
previous studies that have observed a linkage between MK2
and ERK1/2 signaling (Aldridge et al., 2009; Coxon et al., 2003),
whichmay also operate duringmyogenesis. Finally, p38a activity
decreased marginally during the time course studied (Figure 3C)
and appeared to be negatively correlatedwith phopho-p38 levels
while being positively correlated with total p38 expression, as
observed by western blotting (Figure 3C, inset). Importantly,
currently available phospho-p38 antibodies do not distinguish
between p38 isoforms (a, b, g, and d). Indeed, our observed
pattern of p38a activity agrees with assays performed on kinase
immunoprecipitated with antibodies that specifically recognize
this isoform, regardless of phosphorylation status (Perdiguero
et al., 2007). The inability to resolve p38 isoform activation with
currently available antibodies has lead to the use of mice ex-
pressing reduced amounts of each p38 isoform (a, b, g, and d)212 Chemistry & Biology 19, 210–217, February 24, 2012 ª2012 Elseor RNA interference to identify essential p38 isoforms for myo-
genesis (Perdiguero et al., 2007; Wang et al., 2008). However,
these relatively complex genetic analyses have been unable to
identify the p38 isoform observed using phosphospecific anti-
bodies. Our data suggest that the observed increases in the
phosphorylation state of p38 are not due to p38a, but are likely
due to an alternate isoform. Interestingly, p38g transcript (Tomc-
zak et al., 2004) and protein levels (Wang et al., 2008) (Figure 3D)
increase dramatically following mitogen withdrawal in C2C12
cells, and overexpression of this p38 isoform has previously
been shown to stimulate C2C12 differentiation (Lechner et al.,
1996). Previous studies have demonstrated that p38d is not ex-
pressed in C2C12 cells and that p38b expression decreases
dramatically during differentiation in contrast to p38a, which
is expressed throughout the myogenic program (Wang et al.,
2008) (Figure 3D). Furthermore, in vitro activity assays using
immunoprecipitated kinase have demonstrated an increase in
p38g activity during myogenesis (Perdiguero et al., 2007). Taken
together, these observations could account for the observed
increase in theamount of anunidentifiedphosphorylatedp38 iso-
form (Perdiguero et al., 2007). In this light, our observations
support distinct roles for more than one p38 isoform during myo-
genesis (Wang et al., 2008) and are consistent with previous
observations that indicate an essential role for p38a (Perdiguerovier Ltd All rights reserved
Figure 4. Kinase Activity Profiling in Human Tumors
(A) A workflow diagram for analysis of matched tissues using CSox-based kinase activity sensors.
(B) Clinical and histological features of cancer patients.
See also Figure S3.
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12 hr are not resolved in this experiment. These activitymeasure-
ments underscore the utility of direct activity sensors for deter-
mining operative signaling networks during cell differentiation.
A Latitudinal Analysis of Alterations in Kinase Signaling
in Individual Human Tumors
To examine the capability for ascertaining modulations in
multiple kinase enzymatic activities between normal and dis-
eased tissue samples, we selected the problem of comparing
matched tissues from cancer patients in three different pathol-
ogy contexts (Figure 4A). In particular, our panel of activity pro-
bes contains kinases that may have prognostic value and have
been implicated in the development of breast, prostate, and
lung cancers (Feldman and Feldman, 2001; Gustafson et al.,
2010; Musgrove and Sutherland, 2009). Accordingly, we ob-
tained matched tumor and healthy control tissues from patients
diagnosed with these diseases (Figure 4B) and set out to con-
struct individualized kinase activity profiles for each.
Lysates were prepared from each tissue and normalized to
total protein content, which was verified through analysis of
b-actin levels (Figure S3). In order to demonstrate the robust
reproducibility of the observed changes, assays were performed
in triplicate on three independently prepared sets of lysates from
each pair of matched tissues (Figure S3) and were averaged to
obtain individualized patient activity profiles (Figures 5A–5C).
The ease of sample preparation, rapid analysis time (<1 hr),
and simple instrumentation used for data acquisition make this
method practical for potential applications in diagnostic anal-
yses. Moreover, triplicate assays for the entire sensor panel in
96-well format necessitated only 34 mg of tissue, because
typical lysate total protein yields wereR 3 mg/ml. Assays could
also be translated to 384-well plate format (Figure S3), gener-
ating equivalent signal-to-noise while using 4-fold less reagents
and lysate. These activity measurements reflect the specific
biochemistry of individual tumors and could therefore find utility
in both assessing disease state and determining effective treat-
ment strategies (Feldman and Feldman, 2001; Gustafson et al.,
2010; Musgrove and Sutherland, 2009). Indeed in our limited
sample set, we find individual activity profiles that point to (1)
the possible benefit of combining tamoxifen with ERK inhibitors
for the treatment of an individual breast cancer tumor (Musgrove
and Sutherland, 2009) (Figure 5A), (2) increased activity of a
potential marker for aggressive prostate cancer (Pollack et al.,
2009) (Figure 5B), and (3) aberrant activation of p38a and Akt
in a lung cancer tumor (Greenberg et al., 2002; Gustafson
et al., 2010) (Figure 5C). The implications of these unique activity
profiles are discussed in further detail below.Chemistry & Biology 19, 210In the breast tumor samples, clear enhancements in p38a
(3.2 ± 0.34-fold), MK2 (2.7 ± 0.11-fold), and ERK1/2 (2.7 ±
0.15-fold) activities were observed relative to surrounding
normal tissue (Figure 5A). These alterations in activity were sup-
ported by western blot analysis (Figure 5A, inset). The expres-
sion of estrogen, progesterone, and ErbB2 receptors serves to
stratify breast cancer patients and determine clinical treat-
ment strategies (Musgrove and Sutherland, 2009). For example,
patients with estrogen receptor-positive tumors are generally
treated with tamoxifen; however, women treated with tamoxifen
for 5 years still have a 33% recurrence rate after 15 years (Mus-
grove and Sutherland, 2009). Accordingly, diagnostic methods
to predict potential resistance to endocrine therapy are needed.
In this context, the observed increase in ERK1/2 activity along
with receptor status (Figure 5A) provide potential insights into
patient-specific responses to traditional therapy, because this
kinase has been linked to the development of tumors that
are resistant to endocrine therapy (Musgrove and Sutherland,
2009). Moreover, the current difficulty in classifying tumors
according to perturbations in enzyme activity is thought to
have contributed to the variable results obtained in clinical trials
that attempted to resensitize tamoxifen-resistant tumors through
administration of ERK inhibitors (Musgrove and Sutherland,
2009). These results suggest that information from direct kinase
activity measurements may be useful for identifying individuals
who could benefit from combination therapy.
In the prostate tumor sample analyzed here, only PKA activity
was altered when compared to surrounding normal tissue, with
an increase in activity of 1.8 ± 0.08-fold (Figure 5B). A variety
of mechanisms for progression of prostate cancers toward
androgen independence in response to traditional androgen
deprivation therapy have been described, including activation
of ERK and Akt (Feldman and Feldman, 2001). Unfortunately,
tumors that have progressed to androgen independence gener-
ally lead to poor clinical outcomes. Consequently, methods
capable of identifying individuals at risk for progression to
androgen-independent cancers would be helpful in diagnostic
applications. These data suggest that this particular tumor may
not have progressed to an androgen-independent state as
assessed through activation of either the ERK or Akt pathways
(Feldman and Feldman, 2001). However, a recent study moni-
toring 313 patients with prostate cancer suggests that increases
in PKA activity correlate with poor clinical outcomes in response
to traditional androgen deprivation therapy (Pollack et al., 2009),
indicating that quantitative knowledge of PKA activity would be
useful for providing information on individual disease status.
In the individual lung cancer tumor, an increase in MK2 (2.0 ±
0.06-fold) and Akt (2.3 ± 0.35-fold) along with comparably more–217, February 24, 2012 ª2012 Elsevier Ltd All rights reserved 213
Figure 5. Individualized Kinase Activity Profiles for Clinical Cancer Patients
(A–C) Activities of the indicated kinases in cancerous (C, red) relative to normal (N, blue) breast, prostate and lung tissues, respectively. Distinct changes in kinase
activity profiles are observed for each patient and correlate to western blots shown in each inset. The left inset in (A) indicates receptor status for the corre-
sponding tumor. Data represent the average ± SEM of nine total kinase activity assays performed on three independent lysate preparations of each individual set
of matched tissues.
See also Figure S3.
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observed (Figure 5C). This aberrant increase in p38a activity
was confirmed using western blot analysis and did not appear
to be due to an increase in global p38 expression levels, whereas
the observed increase in Akt activity correlated with an increase
in Akt expression (Figure 5C, inset). Unfortunately, effective
treatments for lung cancer, the leading cause of cancer-related
deaths, have not been identified. Previous studies have indi-
cated that an increase in Akt activity may be linked to lung cancer
progression (Gustafson et al., 2010). The individualized kinase
activity profile developed in this study is consistent with these
reports, revealing a distinct change (2.4-fold) in Akt activity in nor-
mal versus cancerous lung tissue (Figure 5C). Taken together,
these data provide corroborating evidence for Akt activation
and also confirm p38 as a potential therapeutic target in lung
cancer (Greenberg et al., 2002), with p38a contributing substan-
tially to the observed increase in phospho-p38 using western
blot analysis (Figure 5C).
Finally, it should be noted that extensive control experiments,
including inhibitor assays and immunodepletions (Figure S1)
(Lukovic et al., 2009; Stains et al., 2011), were performed to
demonstrate the selectivity of the sensor panel in the presence
of endogenous kinases under the described assay condi-
tions. Nonetheless, relatively small contributions from off-target
kinases cannot be ruled out in the absence of an exhaustive
kinetic analysis of every active human kinase. Consequently,
kinase activity alterations are verified through traditional western
blotting analysis, highlighting the importance of complementary
approaches to measuring kinase activities in complex systems.
SIGNIFICANCE
There is a pressing need for robust technologies to enable
direct, quantitative protein kinase activity profiling in basic
cell biology, medical diagnostics, and therapeutic agent
development. Current methods rely heavily on antibody- or
mass spectrometry-based approaches that interrogate pro-214 Chemistry & Biology 19, 210–217, February 24, 2012 ª2012 Elsexies for kinase activity. In this article, we demonstrate
the power of fluorescence-based kinetic analysis, using
the CSox amino acid coupled with kinase-selective sub-
strates, to provide directmeasurements of kinase enzymatic
activity. Although some residual off-target kinase activity is
possible, because the existing panel of sensors has not been
assayed against every knownhumankinase, this limitation is
outweighed by the significant advantages of a fluorescence-
based kinetic assay. In particular, this study demonstrates
that CSox-based probes are capable of providing direct,
quantitative readouts of kinase enzymatic activity that
clarify the biochemistry of cellular differentiation and indi-
vidual human tumors. This work provides a proof of principle
for expansion to larger sample sizes in order to delineate
common perturbations in kinase activities in a given dis-
ease. The generality of this sensing strategy also allows
for the addition of virtually any kinase of interest to the panel,
provided an appropriate substrate sequence can be identi-
fied. Currently, our laboratories are working toward expand-
ing the CSox repertoire as well as determining the prog-
nostic value of kinase activity profiling through the study
of larger patient populations.
EXPERIMENTAL PROCEDURES
General Reagents
All reagents were of ultrapure, metals-free grade where possible. Buffer 1 is
50 mM Tris-HCl (pH = 7.5 at 25C), 10 mM MgCl2, 1 mM EGTA, 2 mM DTT,
and 0.01% Brij-35-P. Buffer 2 is 50 mM Tris (pH = 7.5 at 25C), 150 mM
NaCl, 50 mM b-glycerophosphate, 10 mM sodium pyrophosphate, 30 mM
NaF, 1% Triton X-100, 2 mM EGTA, 100 mM Na3VO4, 1 mM DTT, protease
inhibitor cocktail III (10 ml/ml, Calbiochem, 539134), and phosphatase inhibitor
cocktail 1 (10 ml/ml, Sigma, P2825).
Synthesis of Kinase Activity Probes
Sensors were synthesized and characterized as described previously (Lukovic
et al., 2008; Lukovic et al., 2009; Stains et al., 2011). All peptide-based sensors
were acetyl-capped at the N terminus and included a C-terminal amide. Con-
centrations were determined on the basis of the Sox chromophore byvier Ltd All rights reserved
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Na2EDTA (extinction coefficient = 8427 M
1cm1) (Lukovic et al., 2008).
Cell Culture and Lysate Preparation
HepG2 human hepatocarcinoma cells (ATCC, HB-8065) and HT-29 colorectal
adenocarcinoma cells (ATCC, HTB-38) were propagated on tissue culture
plastic in either Eagle’s minimum essential medium (EMEM, ATCC, HepG2)
or McCoy’s 5a modified medium (ATCC, HT-29) supplemented with 10%
FBS (Hyclone, Thermo Scientific) and 1% penicillin/streptomycin (Invitrogen)
in a humidified incubator at 37C and 5% CO2. Prior to stimulation to activate
specific kinases, HepG2 cells were plated at 1 3 105 cells/cm2 on collagen-I
coated 6-well plates (BD Biocoat, Becton Dickinson) and HT-29 cells were
plated at 1 3 105 cells/cm2 on tissue culture treated plastic 6-well plates or
10-cm dishes for inhibitor studies and immmunodepletions, respectively.
Both cell types were grown for 24 hr in their respective full medium. Cells
were then serum-starved in serum-free medium for 18 hr and dosed with either
NaCl (250mM) for 30min, insulin (Sigma, I9278, 500 ng/ml) for 5min, or forsko-
lin (Cell Signaling, 3828, 30 mM) for 15 min. Pretreatment with the upstream
kinase inhibitors SB202190 (Calbiochem, 559388), LY294002 (Calbiochem,
440204), or wortmannin (Calbiochem, 681675) was accomplished by adding
the indicated molar concentrations to serum-free media 1 hr prior to stimula-
tion. Inhibitor dilutions were prepared such that cells experienced a constant
DMSO concentration of 0.1% for all dosing conditions. At the indicated time
points, cells were washed with ice-cold PBS and lysed on ice in Buffer 2.
Lysates were incubated on ice for 15 min and were clarified by centrifugation.
Supernatants were flash frozen in liquid nitrogen and stored at 80C. These
lysates were used to validate second generation CSox-based activity probes
for MK2, Akt, and PKA. These experiments demonstrated that less sensor and
cell lysate could be used to obtain robust signal-to-noise with the second
generation of probes and that inhibitors could be removed from assays
for MK2.
HeLa cells were propagated in DMEM (Invitrogen, 11995) supplemented
with 10% heat-inactivated FBS and 1% penicillin/streptomycin in a humidified
incubator at 37C and 5% CO2. NIH 3T3 cells were propagated in DMEM
supplemented with 10% FBS and 1% penicillin/streptomycin in a humidified
incubator at 37C and 5% CO2. Prior to stimulation cells were starved
for 18 hr in DMEM supplemented with 2 mM L-Gln, and 1% penicillin/
streptomycin. Sorbitol was then added to a final concentration of 300 mM,
and lysates were prepared after 1 hr as indicated above using Buffer 2.
C2C12 myoblasts (ATCC, CRL-1772) were propagated in DMEM supple-
mented with 20% FBS and grown in a humidified incubator with a 10% CO2
atmosphere. Prior to mitogen withdrawal, cells were seeded onto 150-mm
collagen-I-coated dishes (BD Biosciences, 354551) at 40% confluency. At
95% confluency (time 0) cells were switched to DMEM supplemented with
2% horse serum. This medium was replenished daily during differentiation.
Lysates were prepared from two separate passages of cells at the indicated
time points using the following procedure. Cells were washed with ice-cold
PBS and lysed on ice in Buffer 2. Lysates were clarified by centrifugation
and supernatants were flash frozen in liquid nitrogen and stored at 80C.
Total protein concentrations for all cell lysates were determined using the
BioRad protein assay (500-0006) with BSA as a standard. Lysates were
prepared from two separate passages of cells.
Images and videos were acquired using an Olympus IX50 inverted micro-
scope equipped with a 403 phase contrast objective and a QImaging Retiga
2000R camera.
Hierarchical Clustering Analysis
Fold changes in kinase activity were determined relative to time 0 and
hierarchical clustering analysis was performed in MATLAB using the built-in
Bioinformatics Toolbox with the Euclidean distance metric.
Immunodepletion
HT-29 cells were propagated, plated, starved, stimulated with insulin, and
lysed as described above. The flash frozen lysates were thawed on ice and ali-
quotted in replicates of 500 mg total protein for depleted and control conditions
and brought to 100 ml final volume in buffer 2. Lysateswere then incubated with
either 4 mg of anti-Akt/PKB PH domain 1 antibody (Millipore, 05-591) for Akt
immunodepletion or 4 mg of normalmouse IgG (Santa Cruz, sc-2025) as a naiveChemistry & Biology 19, 210antibody control for 2 hr at 4C on a rotator. Samples were then incubated with
40 ml of Protein G sepharose beads (GE Healthcare, 17-0618-01) for 1 hr at 4C
on a rotator. Beads were then pelleted, and supernatants were collected and
subjected to two additional rounds of immunodepletion. An input control
lysate was aliquoted and kept on ice during all rounds of immunodepletion
to account for sample and kinase activity loss during incubation and liquid
transfer steps. All lysates were then assayed for Akt kinase activity as
described below.
Tissue Lysate Preparation
Tissues were obtained from surgical discards through the National Disease
Research Interchange (NDRI) in accordance with an institutional review
board-approved protocol from the MIT Committee On the Use of Humans
as Experimental Subjects. Tissue samples were flash frozen in liquid nitrogen
as soon as possible (1 hr) after surgery. The guidelines for procurement of
snap-frozen tissue may vary slightly because tissues are procured from
various surgical sites. Frozen tissues were dissected into 100 mg sections,
placed in a 50 ml conical tube, and washed thoroughly with ice-cold PBS.
Lysates were prepared by the addition of 3 volumes (in microliters) of Buffer
2 per mg of tissue and subsequent homogenization on ice with an Omni tissue
homogenizer equipped with a plastic homogenizing probe for hard tissues.
Samples were then incubated on ice for 1 hr, followed by clarification by
centrifugation. The supernatants were collected by piercing the lipid layer
and were flash frozen and stored at 80C. Total protein concentrations
were determined using the BioRad protein assay (500-0006) with BSA as
the standard.
Cell and Tissue Lysate Assays
Assays were conducted as previously described (Lukovic et al., 2009; Stains
et al., 2011) using the following concentrations of substrates and amounts of
lysate for each of the indicated kinases: p38a (1 mM substrate and 10 mg
lysate), MK2 (2.5–5 mM substrate and 10–20 mg lysate), ERK1/2 (5 mM
substrate and 40 mg lysate), Akt (2.5–5 mM substrate and 10–20 mg lysate),
and PKA (10 mM substrate and 20 mg lysate). Inhibitors of off-target kinases
were included in assays for p38a (Stains et al., 2011) (1 mM staurosporine),
Akt (Shults et al., 2005) (4 mM PKC inhibitor peptide, 4 mM calmidazolium,
and 5 mM GF109203X; control experiments demonstrated that addition of
PKItide did not influence the rate of phosphorylation of the Akt sensor), and
PKA (Shults et al., 2005) (4 mM PKC inhibitor peptide, 4 mM calmidazolium,
and 5 mM GF109203X). The activity of p38a was determined by background
subtraction in each lysate using 1 mM SB203580 (Stains et al., 2011). Reac-
tions were prepared in Buffer 1 and contained 1 mM ATP, final reaction
volumes were 120 ml. Assays were performed in half-area 96-well plates
(Corning, 3992), and fluorescence was monitored at 485 nm by exciting at
360 nm using a 455 nm cutoff on a Spectramax Gemini XS plate reader
(Molecular Devices) at 30C. Slopes were determined using linear fits from
Excel during the time in which fluorescence increases were linear with respect
to time (typically 15–60 min); fits are corrected for lag times in the reaction.
Assays with the direct MK2 inhibitor, MK2 Inhibitor III (Calbiochem, 475864),
were conducted using NaCl-stimulated HepG2 lysates in presence of the indi-
cated concentration of inhibitor; DMSO concentrations were 1% in the assay.
Assays with the direct PKA inhibitors, H89 (Cell Signaling, 9844) and PKItide
(Shults et al., 2005), were conducted using forskolin-stimulated HepG2
lysates in the presence of the indicated concentration of inhibitor, in the
case of H89 DMSO concentrations were 3% in the assay. The average fold
changes for biological replicates of C2C12 lysate and tissue preparations
were determined from each individual assay and errors were propagated
accordingly.
384-Well Plate Assays
Assays for MK2 activity in 384-well plates (MatriCal, MP101-1-PS) were con-
ducted in a total volume of 30 ml using 5 mMMK2 substrate and 5 mg of lysate;
reactions were overlaid with 20 ml of white, light mineral oil prior to recording
fluorescence.
Western Blot Analysis
Lysates (20–100 mg total protein) were separated using 12% SDS-PAGE gels,
except for myosin heavy chain which was resolved on a 4%–20% gradient gel–217, February 24, 2012 ª2012 Elsevier Ltd All rights reserved 215
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Interrogating Signaling via Kinase Activity Probes(BioRad, 161-1159). Proteins were transferred to a nitrocellulose membrane.
Blots were probed with primary antibodies for myogenin (Santa Cruz Biotech-
nology, sc-12732), myosin heavy chain (R&D Systems, MAB4470), tubulin (Ab-
cam, ab59680), phospho-p38 (Cell Signaling, 9215), total p38 (Cell Signaling,
9212), p38a (Cell Signaling, 9218), p38g (Cell Signaling, 2307), phospho-
ERK1/2 (Cell Signaling, 4377), total ERK1/2 (Millipore, 06-182), phospho-Akt
(Cell Signaling, 9271), total Akt (Cell Signaling, 4685), or b-actin (Abcam,
ab8227), which were detected using an HRP conjugated goat anti-rabbit
(Pierce, 32460) or goat anti-mouse (Pierce, 32430) secondary antibody where
appropriate. Blots were visualized by enhanced chemiluminescence (Pierce,
34075).
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and one movie and can be
found with this article online at doi:10.1016/j.chembiol.2011.11.012.
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